H. Rochant

发表

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors

J. Mary, M. Leporrier, G. Socié, 1996, The Lancet.

Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group.

E. Archimbaud, J. Extra, J. Sotto, 1987, Haematology and blood transfusion.

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

E. Solary, E. Wattel, P. Fenaux, 1999, Leukemia.

Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.

E. Solary, H. Tilly, E. Wattel, 1999, Advances in experimental medicine and biology.

195 Autologous bone marrow (ABMT) or peripheral blood stem cell (ABSCT) transplantation after intensive chemotherapy in myelodysplastic syndromes (MDS)

A. Stamatoullas, E. Solary, P. Fenaux, 1997 .

Intensive Therapy of Myelodysplastic Syndromes and Secondary Leukemias: Preliminary Findings of the French Experience

E. Solary, H. Tilly, E. Wattel, 1997 .

A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.

H. Tilly, F. Bauters, N. Ifrah, 1993, Leukemia & lymphoma.

Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit.

J. Duval, R. Leclercq, C. Cordonnier, 1995, The Journal of hospital infection.

Clinical course and complications Signs and symptoms None Clinical symptoms Abdominal pain Thrombosist Infectious disease Peripheral blood abnormalities Anaemia alone Anaemia and thrombocytopenia Anaemia and neutropenia Pancytopenia

J. Mary, M. Leporrier, G. Socié, 2005 .

Cost of allogeneic bone marrow transplantation in four diseases.

D. Jolly, C. Griscelli, C. Viens-Bitker, 1989, Health policy.

[Calculation of direct standard costs in the evaluation of new technologies: application to the treatment of acute myeloblastic leukemias].

D. Jolly, C. Viens-Bitker, C. Cordonnier, 1986, Revue d'epidemiologie et de sante publique.

A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.

H. Tilly, J. Tanzer, F. Bauters, 1991, European journal of cancer.

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

J. Mary, A. de Gramont, M. Leporrier, 1996, Lancet.